Cytosorbents Corporation (CTSO)
USD 0.86
(5.91%)
USD 0.86
(5.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 36.34 Million | 29.36 Million | 40.1 Million | 39.45 Million | 22.76 Million | 20.25 Million |
| Cost of Revenue | 13.95 Million | 13.95 Million | 11.04 Million | 11.05 Million | 7.36 Million | 7.48 Million |
| Gross Profit | 22.39 Million | 15.4 Million | 29.06 Million | 28.4 Million | 15.4 Million | 12.76 Million |
| Operating Expenses | 48.33 Million | 46.92 Million | 51.8 Million | 38.77 Million | 34.37 Million | 28.34 Million |
| Selling, General and Administrative Expenses | 37.87 Million | 37.13 Million | 38.48 Million | 31.51 Million | 24.46 Million | 22.87 Million |
| Research and Development Expenses | 15.72 Million | 15.11 Million | 16.38 Million | 8.81 Million | 12.09 Million | 7.72 Million |
| Other Expenses | - | -5.32 Million | -3.05 Million | -1.55 Million | -2.18 Million | -2.25 Million |
| Cost and Expenses | 67.55 Million | 60.88 Million | 62.85 Million | 49.82 Million | 41.74 Million | 35.83 Million |
| Operating Income | -31.2 Million | -31.52 Million | -22.74 Million | -10.37 Million | -18.97 Million | -15.58 Million |
| Interest Expense | 157.89 Thousand | 132.59 Thousand | - | 1.2 Million | 1.03 Million | 1.46 Million |
| Income Tax Expense | -813.73 Thousand | -1.09 Million | -736 Thousand | -1.12 Million | -1.09 Million | -619.54 Thousand |
| Earnings before Tax | -29.32 Million | -33.9 Million | -25.29 Million | -8.96 Million | -20.35 Million | -17.83 Million |
| Net Income | -28.5 Million | -32.81 Million | -24.55 Million | -7.83 Million | -19.26 Million | -17.21 Million |
| Earnings Per Share Basic | -0.64 | -0.75 | -0.57 | -0.20 | -0.60 | -0.56 |
| Earnings Per Share Diluted | -0.64 | -0.75 | -0.57 | -0.20 | -0.60 | -0.56 |
| Weighted Average Shares Outstanding | 44.65 Million | 43.57 Million | 43.35 Million | 38.81 Million | 32.25 Million | 30.71 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.65 Million | 43.57 Million | 43.35 Million | 38.81 Million | 32.25 Million | 30.71 Million |
| Gross Margin | 0.62 | 0.52 | 0.72 | 0.72 | 0.68 | 0.63 |
| EBIT Margin | -0.79 | -0.99 | -0.50 | -0.26 | -0.83 | -0.75 |
| Profit Margin | -0.78 | -1.12 | -0.61 | -0.20 | -0.85 | -0.85 |
| EBITDA | -28.81 Million | -30 Million | -22.01 Million | -9.7 Million | -18.74 Million | -15.97 Million |
| Earnings Before Tax Margin | -0.86 | -1.07 | -0.57 | -0.26 | -0.83 | -0.77 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 9.89 Million | 9.78 Million | 36.34 Million | 8.66 Million | 7.75 Million | 8.07 Million |
| Cost of Revenue | 3.39 Million | 3.21 Million | 13.95 Million | 3.35 Million | 3.2 Million | 3.4 Million |
| Gross Profit | 6.5 Million | 6.57 Million | 22.39 Million | 5.31 Million | 4.55 Million | 4.67 Million |
| Operating Expenses | 9.73 Million | 11.43 Million | 52.94 Million | 14.47 Million | 11.9 Million | 11.22 Million |
| Selling, General and Administrative Expenses | 7.58 Million | 8.56 Million | - | 9.24 Million | 9.2 Million | 8.9 Million |
| Research and Development Expenses | 1.51 Million | 2.24 Million | - | 4.09 Million | 3.74 Million | 3.66 Million |
| Other Expenses | -635.73 Thousand | -616.71 Thousand | -3.61 Million | -1.13 Million | -920.47 Thousand | - |
| Cost and Expenses | 13.12 Million | 14.64 Million | 66.9 Million | 17.82 Million | 15.1 Million | 14.63 Million |
| Operating Income | -3.23 Million | -4.86 Million | -30.55 Million | -9.16 Million | -7.35 Million | -6.55 Million |
| Interest Expense | -180.09 Thousand | -6653.00 | 157.89 Thousand | 52.22 Thousand | 34 Thousand | -8821.00 |
| Income Tax Expense | -4.00 | -3.00 | -813.73 Thousand | -813.73 Thousand | -428.64 Thousand | -406.15 Thousand |
| Earnings before Tax | -4.14 Million | -6.35 Million | -29.32 Million | -6.64 Million | -9.19 Million | -6.15 Million |
| Net Income | -4.14 Million | -6.35 Million | -28.5 Million | -5.83 Million | -9.19 Million | -6.15 Million |
| Earnings Per Share Basic | -0.08 | -0.12 | - | -0.12 | -0.21 | -0.14 |
| Earnings Per Share Diluted | -0.08 | -0.12 | - | -0.12 | -0.21 | -0.14 |
| Weighted Average Shares Outstanding | 54.3 Million | 54.26 Million | 44.65 Million | 48.62 Million | 44.37 Million | 44.01 Million |
| Weighted Average Shares Outstanding (Diluted) | 54.3 Million | 54.26 Million | 44.65 Million | 48.62 Million | 44.37 Million | 44.01 Million |
| Gross Margin | 0.66 | 0.67 | 0.62 | 0.61 | 0.59 | 0.58 |
| EBIT Margin | -0.28 | -0.45 | - | -0.97 | -0.95 | -0.81 |
| Profit Margin | -0.42 | -0.65 | -0.78 | -0.67 | -1.19 | -0.76 |
| EBITDA | -2.78 Million | -4.41 Million | - | -8.36 Million | -7.35 Million | -6.51 Million |
| Earnings Before Tax Margin | -0.33 | -0.50 | -0.84 | -1.06 | -0.95 | -0.81 |
GVFF
007980
TATT
AIROLAM
ALOD
OSM